Atlas Trials

A Study to Evaluate the Effect of BioK+ 50B® on Glycemic Control in a Type 2 Diabetes Population

Clinical trial NCT03239366 · UNKNOWN

Trial details

NCT number
NCT03239366
Sponsor
Bio-K Plus International Inc.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Type2 Diabetes
Start date
2017-09-06
Primary completion
2019-02-01
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.